EISAI INC. for EISAI INC.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
HR 1 Tax Cut and Jobs Act -- Issues related to corporate tax reform
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIMOTHY CLARK | — |
Medicare/Medicaid MMM
Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of FDA-approved obesity drugs. H.R. 1953/S. 830 - Treat and Reduce Obesity Act of 2017 Revisions to Medicare reimbursement programs on obesity interventions
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIMOTHY CLARK | — |
Health Issues HCR
Regulatory and legislative health care issues impacting pricing and access in the following legislation: S. ____ - Better Care Reconciliation Act (BCRA) - To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017. S. 204/H.R. 878 - Trickett Wendler Right To Try Act of 2017 S. 456/H.R. 1231 - Research to Accelerate Cures and Equity (RACE) for Children Act S. 870 - Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 Regulatory and legislative health care issues, including the 340B program Issues related to the treatment of obesity Drug Cost and Pricing
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIMOTHY CLARK | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.